Xiangxue Pharmaceutical Statistics

Total Valuation

SHE:300147 has a market cap or net worth of CNY 5.69 billion. The enterprise value is 8.27 billion.

Market Cap	5.69B
Enterprise Value	8.27B

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300147 has 661.28 million shares outstanding. The number of shares has decreased by -10.12% in one year.

Current Share Class	661.28M
Shares Outstanding	661.28M
Shares Change (YoY)	-10.12%
Shares Change (QoQ)	+1.98%
Owned by Insiders (%)	0.30%
Owned by Institutions (%)	4.18%
Float	483.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.32
PB Ratio	4.19
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.08
EV / Sales	4.84
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-73.26

Financial Position

The company has a current ratio of 0.28, with a Debt / Equity ratio of 1.66.

Current Ratio	0.28
Quick Ratio	0.19
Debt / Equity	1.66
Debt / EBITDA	n/a
Debt / FCF	-19.93
Interest Coverage	-1.17

Financial Efficiency

Return on equity (ROE) is -50.10% and return on invested capital (ROIC) is -4.13%.

Return on Equity (ROE)	-50.10%
Return on Assets (ROA)	-2.19%
Return on Invested Capital (ROIC)	-4.13%
Return on Capital Employed (ROCE)	-16.48%
Revenue Per Employee	617,844
Profits Per Employee	-328,867
Employee Count	2,769
Asset Turnover	0.22
Inventory Turnover	3.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +136.26% in the last 52 weeks. The beta is 0.49, so SHE:300147's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	+136.26%
50-Day Moving Average	7.15
200-Day Moving Average	9.29
Relative Strength Index (RSI)	60.05
Average Volume (20 Days)	30,322,213

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300147 had revenue of CNY 1.71 billion and -910.63 million in losses. Loss per share was -1.40.

Revenue	1.71B
Gross Profit	327.25M
Operating Income	-274.68M
Pretax Income	-894.43M
Net Income	-910.63M
EBITDA	-60.04M
EBIT	-274.68M
Loss Per Share	-1.40

Full Income Statement

Balance Sheet

The company has 57.52 million in cash and 2.25 billion in debt, giving a net cash position of -2.19 billion or -3.32 per share.

Cash & Cash Equivalents	57.52M
Total Debt	2.25B
Net Cash	-2.19B
Net Cash Per Share	-3.32
Equity (Book Value)	1.36B
Book Value Per Share	1.43
Working Capital	-4.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -90.10 million and capital expenditures -22.82 million, giving a free cash flow of -112.92 million.

Operating Cash Flow	-90.10M
Capital Expenditures	-22.82M
Free Cash Flow	-112.92M
FCF Per Share	-0.17

Full Cash Flow Statement

Margins

Gross margin is 19.13%, with operating and profit margins of -16.06% and -53.23%.

Gross Margin	19.13%
Operating Margin	-16.06%
Pretax Margin	-52.28%
Profit Margin	-53.23%
EBITDA Margin	-3.51%
EBIT Margin	-16.06%
FCF Margin	n/a

Dividends & Yields

SHE:300147 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	10.12%
Shareholder Yield	n/a
Earnings Yield	-16.01%
FCF Yield	-1.99%

Dividend Details

Stock Splits

The last stock split was on July 14, 2014. It was a forward split with a ratio of 1.3.

Last Split Date	Jul 14, 2014
Split Type	Forward
Split Ratio	1.3

Scores

SHE:300147 has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.4
Piotroski F-Score	n/a